Department of Community Health Sciences, Boston University School of Public Health, Boston, MA, USA.
Centers for Behavioral and Preventative Medicine, The Miriam Hospital, Providence, RI, USA.
Transl Behav Med. 2020 Oct 12;10(5):1211-1220. doi: 10.1093/tbm/ibaa007.
The use of mobile health (mHealth) technologies addressing HIV disparities among gay, bisexual, and other men who have sex with men (GBMSM) has increased. A systematic review of mHealth interventions for HIV prevention and treatment among GBMSM was conducted to summarize the current evidence and provide recommendations for future research. PRISMA guidelines were followed (PROSPERO ID: 148452). Studies identified via PubMed, PsychInfo, or Embase were included that (i) were in English, (ii) were published in a peer-reviewed journal prior to July 1, 2019, (iii) presented primary results, (iv) included only GBMSM, and (v) reported the results of an mHealth intervention (e.g., text message, phone/mobile application [app]) to improve HIV prevention or treatment outcomes. Of 1,636 identified abstracts, 16 published studies met inclusion criteria. Eleven studies were conducted in the United States. One study was a fully powered randomized controlled trial (RCT), seven were single-arm pilots with pre-post assessments, four were pilot RCTs, and four tested public health campaigns with post-assessments. Seven developed study-specific apps, five used text messaging, and four used existing social networking apps. Most (81%) targeted prevention outcomes. Nine cited a specific behavioral theory. All studies found that a mHealth approach was feasible and acceptable. All interventions provided evidence of preliminary efficacy or promising trends on primary outcomes. Although mHealth interventions for HIV prevention and treatment appear feasible and acceptable, most published studies are small pilot trials. Additional research assessing the efficacy and mechanisms of mHealth interventions is needed.
移动医疗(mHealth)技术在解决男同性恋者、双性恋者和其他与男性发生性关系的男性(GBMSM)中的艾滋病毒差异方面的使用有所增加。对针对 GBMSM 的艾滋病毒预防和治疗的 mHealth 干预措施进行了系统评价,以总结当前的证据并为未来的研究提供建议。遵循 PRISMA 指南(PROSPERO ID:148452)。通过 PubMed、PsychInfo 或 Embase 确定的研究包括:(i)使用英语;(ii)在 2019 年 7 月 1 日之前在同行评议的期刊上发表;(iii)提出主要结果;(iv)仅包括 GBMSM;(v)报告 mHealth 干预措施(例如,短信,电话/移动应用程序[app])改善艾滋病毒预防或治疗结果的结果。在 1636 篇摘要中,有 16 项已发表的研究符合纳入标准。其中 11 项在美国进行。一项研究是完全有力量的随机对照试验(RCT),7 项是具有前后评估的单臂试验,4 项是试点 RCT,4 项是具有后评估的公共卫生运动。其中 7 项开发了特定于研究的应用程序,5 项使用了短信,4 项使用了现有的社交网络应用程序。大多数(81%)针对预防结果。9 项引用了特定的行为理论。所有研究均发现 mHealth 方法是可行且可接受的。所有干预措施均对主要结果提供了初步疗效或有希望的趋势的证据。尽管用于艾滋病毒预防和治疗的 mHealth 干预措施似乎是可行且可接受的,但大多数已发表的研究都是小型试点试验。需要进一步研究来评估 mHealth 干预措施的疗效和机制。
Bull World Health Organ. 2024-12-1
MMWR Morb Mortal Wkly Rep. 2019-5-31
JMIR Mhealth Uhealth. 2018-9-10
Am J Prev Med. 2018-6-28